Zobrazeno 1 - 10
of 649
pro vyhledávání: '"Thomas Forst"'
Autor:
Oliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, Antonio Ceriello, Helena Elding Larsson, Beatriz Fernández-Fernández, Thomas Forst, Juan-Pablo Frias, James R. Gavin, Francesco Giorgino, Per-Henrik Groop, Hiddo J. L. Heerspink, Stephan Herzig, Michael Hummel, George Huntley, Mahmoud Ibrahim, Baruch Itzhak, Stephan Jacob, Linong Ji, Mikhail Kosiborod, Nebosja Lalic, Sofia Macieira, Rayaz A. Malik, Boris Mankovsky, Nikolaus Marx, Chantal Mathieu, Timo D. Müller, Kausik Ray, Helena W. Rodbard, Peter Rossing, Lars Rydén, Petra-Maria Schumm-Draeger, Peter Schwarz, Jan Škrha, Frank Snoek, Frank Tacke, Bruce Taylor, Britta Tendal Jeppesen, Solomon Tesfaye, Pinar Topsever, Tina Vilsbøll, Xuefeng Yu, Eberhard Standl
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-17 (2024)
Abstract The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform for in-depth discussions and exch
Externí odkaz:
https://doaj.org/article/167ffccba8024cf1934fce0e0b20bdf0
Autor:
Oliver Schnell, Tadej Battelino, Richard Bergenstal, Andreas L. Birkenfeld, Antonio Ceriello, Alice Cheng, Melanie Davies, Steve Edelman, Thomas Forst, Francesco Giorgino, Jennifer Green, Per-Henrik Groop, Samy Hadjadj, Hiddo J.L.Heerspink, Marcus Hompesch, Baruch Izthak, Linong Ji, Naresh Kanumilli, Boris Mankovsky, Chantal Mathieu, Martin Miszon, Reem Mustafa, Michael Nauck, Roberto Pecoits-Filho, Jeremy Pettus, Kari Ranta, Helena W. Rodbard, Peter Rossing, Lars Ryden, Petra-Maria Schumm-Draeger, Scott D. Solomon, Jan Škrha, Pinar Topsever, Tina Vilsbøll, John Wilding, Eberhard Standl
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract The 8th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Kidney, and Glycemic Outcomes was held virtually on November 10–12, 2022. Following the tradition of previous summits, this reference congress served as a platform for i
Externí odkaz:
https://doaj.org/article/d2025af878514bcdbba126d73d787a44
Autor:
Thomas Forst, Chantal Mathieu, Francesco Giorgino, David C. Wheeler, Nikolaos Papanas, Roland E. Schmieder, Atef Halabi, Oliver Schnell, Marina Streckbein, Katherine R. Tuttle
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background Diabetic kidney disease (DKD), the most common cause of kidney failure and end-stage kidney disease worldwide, will develop in almost half of all people with type 2 diabetes. With the incidence of type 2 diabetes continuing to inc
Externí odkaz:
https://doaj.org/article/62020e62af414e208c77428994711e7b
Autor:
Oliver Schnell, Tadej Battelino, Richard Bergenstal, Matthias Blüher, Michael Böhm, Frank Brosius, Richard D. Carr, Antonio Ceriello, Thomas Forst, Francesco Giorgino, Bruno Guerci, Hiddo J. L. Heerspink, Baruch Itzhak, Linong Ji, Mikhail Kosiborod, Nebojša Lalić, Michael Lehrke, Nikolaus Marx, Michael Nauck, Helena W. Rodbard, Giuseppe M. C. Rosano, Peter Rossing, Lars Rydén, Francesca Santilli, Petra-Maria Schumm-Draeger, Per Olav Vandvik, Tina Vilsbøll, Christoph Wanner, Carol Wysham, Eberhard Standl
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-16 (2022)
Abstract The 7th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Renal, and Glycemic Outcomes, was held virtually on November 18–19, 2021. Pursuing the tradition of the previous summits, this reference congress served as a platform fo
Externí odkaz:
https://doaj.org/article/00e116eff4ae44ebb18f8fbed0bc075e
Autor:
Oliver Schnell, Xavier Cos, Francesco Cosentino, Thomas Forst, Francesco Giorgino, Hiddo J. L. Heersprink, Mikhail Kosiborod, Christoph Wanner, Eberhard Standl
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)
Abstract The 6th Cardiovascular Outcome Trial (CVOT) Summit “Cardiovascular and Renal Outcomes 2020” was the first to be held virtually on October 29–30, 2020. As in previous years, this summit served as reference meeting for in-depth discussio
Externí odkaz:
https://doaj.org/article/ea242afe0c26401ca3536b3bbccb63fc
Autor:
Katharina Schütt, Jens Aberle, Johann Bauersachs, Andreas Birkenfeld, Stefan Frantz, Manfred Ganz, Stephan Jacob, Monika Kellerer, Matthias Leschke, Christoph Liebetrau, Nikolaus Marx, Dirk Müller-Wieland, Philip Raake, Paul Christian Schulze, Diethelm Tschöpe, Stephan von Haehling, Thomas A. Zelniker, Thomas Forst
Publikováno v:
Diabetol. Stoffwechs. 17, 277-288 (2022)
ZusammenfassungDiabetes mellitus (DM) stellt eine wichtige Komorbidität bei Patienten mit Herzinsuffizienz dar, die maßgeblich die Prognose der Patienten determiniert. Von entscheidender Bedeutung zur Verbesserung der Prognose dieser Hochrisiko-Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2839314b6d4753774ae8c539ea3c33
https://doi.org/10.1055/a-1867-3026
https://doi.org/10.1055/a-1867-3026
Autor:
Katharina Schütt, Thomas Forst, Andreas L. Birkenfeld, Andreas Zirlik, Dirk Müller-Wieland, Nikolaus Marx
Publikováno v:
Die Diabetologie. 18:657-660
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94efd063dba404247f0cc1d55cf50606
https://doi.org/10.1007/s11428-022-00916-2
https://doi.org/10.1007/s11428-022-00916-2
Autor:
Thomas Forst
Publikováno v:
Diabetologie und Stoffwechsel. 17:186-196
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e09926e3b7ee6af7901b829224d2814
https://doi.org/10.1055/a-1225-8678
https://doi.org/10.1055/a-1225-8678
Publikováno v:
Diabetologie und Stoffwechsel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e277988a7218ec64a9799c4db82e423d
https://doi.org/10.1055/s-0043-1767991
https://doi.org/10.1055/s-0043-1767991
Autor:
Thomas Forst, Isabel Botz, Matthias Berse, Stephan Voswinkel, Mares-Elaine Strempler, Sybille Baumann, Armin Schultz
Background: The incidence of non-alcoholic fatty liver disease (NAFLD) is rising in parallel with increasing bodyweight and loss of glucose control, implicating a high risk of hepatic and extra-hepatic complications. Subjects / Methods: This longitud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d7fb88ac711edf26df064c8dbe1b634
https://doi.org/10.21203/rs.3.rs-2393464/v2
https://doi.org/10.21203/rs.3.rs-2393464/v2
